D Gothi1, S Spalgais1. Show Affiliations » 1. Department of Pulmonary Medicine, ESI-PGIMSR, New Delhi, India.
Abstract
Entities: Chemical Disease Gene
Mesh： See more » Adenocarcinoma/diagnosisAdenocarcinoma/diet therapyAdultAgedDrug InteractionsErbB Receptors/geneticsErlotinib Hydrochloride/therapeutic useFemaleGefitinibHumansLung/diagnostic imagingLung/pathologyLung Neoplasms/diagnosisLung Neoplasms/diet therapyMaleMutation/geneticsPleural Effusion/diagnosisPleural Effusion/diet therapyProtein Kinase InhibitorsQuinazolines/therapeutic useRadiography, ThoracicTuberculosis/diagnosisTuberculosis/diet therapyTumor Necrosis Factor-alpha/metabolism
Substances： See more » Protein Kinase InhibitorsQuinazolinesTumor Necrosis Factor-alphaErlotinib HydrochlorideEGFR protein, humanErbB ReceptorsGefitinib
Year: 2017 PMID： 29199650 DOI： 10.4103/ijc.IJC_503_16
Source DB: PubMed Journal: Indian J Cancer ISSN： 0019-509X Impact factor: 1.224